Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient

被引：11

作者：

Butani, L ^{[1
]}

Berg, G ^{[1
]}

Makker, SP ^{[1
]}

机构：

[1] Univ Calif Davis, Davis Med Ctr, Sect Pediat Nephrol, Sacramento, CA 95817 USA

来源：

TRANSPLANTATION | 2002年 / 73卷 / 01期

关键词：

D O I：

10.1097/00007890-200201150-00033

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：159 / 160

页数：2

共 7 条

[1]

COHEN DJ, 1994, CLIN TRANSPLANT, V8, P541

[2] TACROLIMUS, A NEW IMMUNOSUPPRESSANT - A REVIEW OF THE LITERATURE [J].

HOOKS, MA .

ANNALS OF PHARMACOTHERAPY, 1994, 28 (04) :501-511

[3] Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine [J].

Lown, KS ;

Mayo, RR ;

Leichtman, AB ;

Hsiao, HL ;

Turgeon, DK ;

SchmiedlinRen, P ;

Brown, MB ;

Guo, WS ;

Rossi, SJ ;

Benet, LZ ;

Watkins, PB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :248-260

[4]

Pesavento TE, 1996, J AM SOC NEPHROL, V7, P831

[5] INHIBITION OF HEPATIC-MICROSOMAL DRUG-METABOLISM BY THE CALCIUM-CHANNEL BLOCKERS DILTIAZEM AND VERAPAMIL [J].

RENTON, KW .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (14) :2549-2553

[6] Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance [J].

Venkatakrishnan, K ;

von Moltke, LL ;

Greenblatt, DJ .

CLINICAL PHARMACOKINETICS, 2000, 38 (02) :111-180

[7] Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients [J].

Wong, KM ;

Shek, CC ;

Chau, KF ;

Li, CS .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :660-666

← 1 →